Alzheimer's disease (AD) is a neurological condition that affects millions of individuals
around the world and for which there are few effective therapies. Dementia is characterized …

Positron emission tomography (PET) is a functional imaging technique that can be used to
visualize physiological activity or molecular processes in the whole body or specific organs …

In the past two decades, the research community has focused on defining reliable molecular
biomarkers for the early diagnosis of Alzheimer's disease (AD). Several positron emission …

Objective: The internet and social media enhance communication, education, and social
connection among users; however, some adverse effects on health are notable, particularly …

Objective: To identify patient characteristics and MR imaging features of hypovascular
hypointense nodules in the hepatobiliary phase (HBP) of gadoxetic acid-enhanced MR …

Background: Earlier differential diagnosis of dementia remains a major challenge. Although
amyloid deposition by positron emission tomography is an emerging standard for the …

In the past two decades, the research community has focused on defining reliable molecular
biomarkers for the early diagnosis of Alzheimer's disease (AD). Several PET …

Alzheimer's disease (AD) is a neurodegenerative disease that occurs in the elderly and is
the most common cause of dementia. The insidious onset and lack of specificity of clinical …

Purpose: While amyloid-β deposition in the cerebral cortex for Alzheimer's disease (AD) is
often evaluated by amyloid positron emission tomography (PET), amyloid-β-related iron can …

Objective: Alzheimer's disease (AD) and subcortical vascular dementia are considered the
most common pathologic contributors to dementia in the aging population. Both frequently …